Humacyte cut roughly 25% of its staff as it trims spending and refocuses commercial efforts for Symvess while preparing for upcoming trial data.

Ukrainian surgeons told Fort Bragg medics that drone swarms are stretching evacuations from minutes to days, forcing new training and underground care plans.

Corning says three new U.S. plants and more than 3,000 jobs will follow a multiyear partnership with Nvidia; the deal includes warrants that could lead to a multi‑billion dollar investment.

Duke researchers trained an AI on routine health records and say it can predict ADHD risk by age 5; the model shows strong accuracy but needs clinical validation.

Wake Forest is part of DAWN, a multinational study recruiting 13,000 Black, Hispanic and African participants to study genetic and biomarker drivers of Alzheimer’s disparities.

Raleigh recruiters say Copilot and chatbots speed resume-building and job matches — but career coaches warn the efficiencies are shrinking entry-level hiring. Surveys back up the gap between faster searches and fewer starter roles.

Levitate raised $16M and plans to hire more than 100 people in Raleigh as it scales its AI-powered relationship-marketing business. The company will also expand offices in Toronto and Wilmington.

NCCU has won a $10M NIH subgrant — part of a Duke-led award — to fund seven years of community-focused medical research, student training and faculty pilot projects. The money will support data dashboards, workforce training and community-engaged studies across 11 departments.

New national data show five‑year lung‑cancer survival has climbed to about 30 percent. Triangle doctors point to immunotherapy, testing and screening as key drivers.

A Duke‑led study in Forsyth County is testing drones that deliver AEDs to 911 cardiac‑arrest calls, lowering devices to bystanders while EMS heads to the scene.

United Therapeutics' Phase 3 ralinepag cut clinical worsening risk by 55% and the company says the drug could be a $2B rival to J&J's Uptravi.

A Triangle Business Journal ranking shows the region’s 25 biggest VC backers raised about $1.5B in 2025, highlighting concentrated capital and a life‑sciences tilt.

Duke researchers found that resident immune cells in the eye’s drainage tissues clear debris and help control pressure; removing them in mice raised intraocular pressure. The work, published in Immunity, points to a new target for glaucoma therapies.